Cancer News and Research

Latest Cancer News and Research

Zhena's Gypsy Tea launches campaign for breast cancer awareness and prevention

Zhena's Gypsy Tea, the innovative tea company, turns up the heat on the battle against breast cancer with its campaign dedicated to urging awareness, preventing breast cancer and finding a cure. Spearheaded by the slogan; Drink Pink-Think Pink, a 70 cent donation of each sale of a the company's popular PINK SUPERBERRY TEA for Women's Health will go directly to The Breast Cancer Research Foundation(R) (BCRF), in support of finding a cure and funding clinical and genetic research worldwide.

15 Sep 2009

Idera Pharmaceuticals to discuss TLR-targeted drug discovery and development programs

Idera Pharmaceuticals, Inc., a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors (TLR), today announced that it will discuss its TLR-targeted drug discovery and development programs and provide a general corporate overview at the UBS Global Life Sciences Conference on Monday, September 21, 2009, at 10:30 a.m. EDT at the Grand Hyatt New York Hotel in New York City.

15 Sep 2009

HFSA meeting highlights increased risk of heart failure among childhood cancer survivors

The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) today featured a discussion titled "Cardiovascular Disease in Survivors of Childhood Cancer" presented by Dr. Ming Hui Chen, Director, Stress Echocardiography Program and Program for Cardiac Health in Cancer Survivors, Children's Hospital Boston.

15 Sep 2009

Council briefing series to examine role of public policy in promoting medical innovation

The Council for American Medical Innovation will host a breakfast briefing on Capitol Hill titled "Translational Research - From Bench to Bedside." Health policy experts will explore important changes needed to improve the process of development and approval for safe and effective drugs, biologics, medical devices and diagnostics.

15 Sep 2009

Biocryst signs agreement with three partners to represent its anti-viral peramivir outside U.S.

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has signed binding letters of intent with three partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities, as well as for marketing and distribution of peramivir for seasonal influenza upon local regulatory approval, within their territories outside the U.S.

15 Sep 2009

Elekta announces interim results

Demand for Elekta’s clinical solutions, products and services remained strong in the first three months of 2009/10. Order bookings rose by 19 percent in local currency with solid performance in all regions. Net sales grew to SEK 1,440 M and operating result rose to SEK 89 M. Earnings per share improved to SEK 0.62 from SEK 0.02.

From Elekta 15 Sep 2009

NYSDOH blocks U.S.-Egypt study of ozone-based medical therapies for diabetic skin ulcers

A study exploring the healing of diabetic skin ulcers using topical oxygen/ozone gas mixtures could not proceed to completion and was now abandoned, according to Ozonics International, LLC, a veteran-owned biotechnology company engaged in the research and development of ozone-based medical therapies.

15 Sep 2009

HUYA Bioscience signs first-look agreement with Chinese Academy of Sciences' GIBH

HUYA Bioscience International, the leader in global pharmaceutical co-development with China, today announced a strategic partnership agreement with Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH). HUYA has established a series of strategic partnerships with Chinese science institutes that affords it the opportunity to expand its portfolio of novel biopharmaceutical products.

15 Sep 2009

Chief of Robotics and Minimally Invasive Surgery shares views on medical tourism

In light of the economy and rising unemployment, people are looking to cut costs wherever they can. As the costs of many surgeries and procedures continue to rise in the US, many are looking for cheaper alternatives abroad. This big business is known as "medical tourism," and often promises healthcare options at a fraction of the cost as in the United States. However, this is one area where bargain shopping is not recommended, counsels Dr. David B. Samadi, Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York City.

15 Sep 2009

New program educates parents on fun, healthy mealtime ideas

How did the simple act of eating become so difficult? Between basic nutrition, the obesity epidemic, allergies, food recalls, and chemical contaminants, feeding children a healthy diet has never been so complicated. Eat Healthy, a new program from Healthy Child Healthy World, makes it easy.

15 Sep 2009

NCF aims to improve cancer care by providing easily accessible tools

The NavigateCancer Foundation (NCF), a nonprofit staffed by oncology professionals, provides patient advocacy tools and services for cancer patients and families, is filling an especially vital role as the ranks of the unemployed and uninsured steadily swell.

15 Sep 2009

Cytheris' INSPIRE study data of HIV-infected patients with low CD4 T cell counts announced

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced presentation of data from an interim analysis of CLI-107-06 (INSPIRE), a Phase I/IIa study of HIV-infected patients with low CD4 T cell counts. The patients were treated with a three-injection cycle of the Company’s investigative immune-modulator, recombinant human Interleukin-7 (CYT107).

15 Sep 2009

UC Irvine's Eclipsys SCM and eLink Interface Engine implementation guided by Orchestrate Healthcare

Orchestrate Healthcare, the leader in healthcare technical consulting and recipient of the 2008 “Best in KLAS” Achievement Award for Technical Services, has partnered with UC Irvine Healthcare to provide technical and managerial guidance in their implementation of the Eclipsys Sunrise Clinical Manager (SCM) and eLink Interface Engine.

15 Sep 2009

PET scanning made as publicly insured health service

Positron Corporation today announced that the Ministry of Health and Long Term Care of Ontario, Canada is making positron emission tomography (PET) scanning a publicly insured health service available to cancer and cardiac patients under conditions where PET scans have been proven to be clinically effective.

15 Sep 2009

Genova gains access to Big Pharma's distribution channels

GENova Biotherapeutics Inc. ("GENova"), a cancer drug acquisition and development company, is pleased to announce it has gained access to distribution channels for its promising drug targets through a recently-signed deal with Bridge BioResearch Plc. ("Bridge BioResearch").

15 Sep 2009

New book on human genetics helps to unravel complex human diseases

Many human diseases-including Alzheimer's disease, schizophrenia, cancer, and cardiovascular disease-are caused by multiple genetic variants and the interaction of those variants with the environment. Because such diseases lack a clear-cut inheritance pattern, sophisticated technological approaches and statistical analyses are required to determine their underlying cause.

15 Sep 2009

Targeted Molecular Diagnostics to offer digital pathology services in Beijing

Targeted Molecular Diagnostics (TMD), a Quintiles Central Laboratory, announced today the availability of digital pathology services in Beijing, China. The services add to Quintiles offerings used in the development of therapies to treat the world’s most pressing health issues, including cancer.

15 Sep 2009

Gentic circuits that cause mucous hyper-production identified

Scientists have identified the main genetic switch that causes excessive mucous in the lungs, a discovery that one day could ease suffering for people with chronic lung diseases like asthma and cystic fibrosis, or just those fighting the common cold.

15 Sep 2009

LLS to invest in research to reduce toxic side-effects of cancer treatment

The cure rates for many cancers have improved dramatically over the past decades, but the harsh reality is that too many cancer survivors suffer serious side-effects of their curative treatments. Toxic side-effects can occur months or years after the treatments are finished, sometimes as chronic conditions, sometimes life-threatening, but always unacceptably reducing a patient's quality of life.

15 Sep 2009

Stem cell therapy holds great promise for regenerative medicine

The recipients of The 2009 Lasker Awards, announced today, represent the dramatic advances achieved in biotechnology research that have led to a revolutionary cancer treatment and the tremendous promise of stem cell therapy for regenerative medicine. Such advances portend a potential $700 million global market for new therapies within less than five years, according to Genetic Engineering & Biotechnology News (GEN, www.genengnews.com).

15 Sep 2009

Cancer News and Research

Latest Cancer News and Research

Zhena's Gypsy Tea launches campaign for breast cancer awareness and prevention

Idera Pharmaceuticals to discuss TLR-targeted drug discovery and development programs

HFSA meeting highlights increased risk of heart failure among childhood cancer survivors

Council briefing series to examine role of public policy in promoting medical innovation

Biocryst signs agreement with three partners to represent its anti-viral peramivir outside U.S.

Elekta announces interim results

NYSDOH blocks U.S.-Egypt study of ozone-based medical therapies for diabetic skin ulcers

HUYA Bioscience signs first-look agreement with Chinese Academy of Sciences' GIBH

Chief of Robotics and Minimally Invasive Surgery shares views on medical tourism

New program educates parents on fun, healthy mealtime ideas

NCF aims to improve cancer care by providing easily accessible tools

Cytheris' INSPIRE study data of HIV-infected patients with low CD4 T cell counts announced

UC Irvine's Eclipsys SCM and eLink Interface Engine implementation guided by Orchestrate Healthcare

PET scanning made as publicly insured health service

Genova gains access to Big Pharma's distribution channels

New book on human genetics helps to unravel complex human diseases

Targeted Molecular Diagnostics to offer digital pathology services in Beijing

Gentic circuits that cause mucous hyper-production identified

LLS to invest in research to reduce toxic side-effects of cancer treatment

Stem cell therapy holds great promise for regenerative medicine

Cancer Research eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Cancer News and Research

Latest Cancer News and Research

Cancer Research eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in